Article ; Online: Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature.
2021 Volume 28, Issue 11, Page(s) 3820–3825
Abstract: ... survivors. The aim of this pooled analysis was to synthesize the prevalence of post-COVID headache ... patients. Time trend analysis showed a decreased prevalence from the acute symptoms' onset to all post ... Background: Headache is identified as a common post-COVID sequela experienced by COVID-19 ...
| Abstract | Background: Headache is identified as a common post-COVID sequela experienced by COVID-19 survivors. The aim of this pooled analysis was to synthesize the prevalence of post-COVID headache in hospitalized and non-hospitalized patients recovering from SARS-CoV-2 infection. Methods: MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers, were searched up to 31 May 2021. Studies or preprints providing data on post-COVID headache were included. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale. Random effects models were used for meta-analytical pooled prevalence of post-COVID headache. Data synthesis was categorized at hospital admission/symptoms' onset, and at 30, 60, 90, and ≥180 days afterwards. Results: From 9573 studies identified, 28 peer-reviewed studies and 7 preprints were included. The sample was 28,438 COVID-19 survivors (12,307 females; mean age: 46.6, SD: 17.45 years). The methodological quality was high in 45% of the studies. The overall prevalence of post-COVID headache was 47.1% (95% CI 35.8-58.6) at onset or hospital admission, 10.2% (95% CI 5.4-18.5) at 30 days, 16.5% (95% CI 5.6-39.7) at 60 days, 10.6% (95% CI 4.7-22.3) at 90 days, and 8.4% (95% CI 4.6-14.8) at ≥180 days after onset/hospital discharge. Headache as a symptom at the acute phase was more prevalent in non-hospitalized (57.97%) than in hospitalized (31.11%) patients. Time trend analysis showed a decreased prevalence from the acute symptoms' onset to all post-COVID follow-up periods which was maintained afterwards. Conclusion: This meta-analysis found that the prevalence of post-COVID headache ranged from 8% to 15% during the first 6 months after SARS-CoV-2 infection. |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MeSH term(s) | Adult ; COVID-19 ; Female ; Headache/epidemiology ; Headache/etiology ; Humans ; Male ; Middle Aged ; Prevalence ; SARS-CoV-2 ; Survivors | ||||||||||
| Language | English | ||||||||||
| Publishing date | 2021-08-08 | ||||||||||
| Publishing country | England | ||||||||||
| Document type | Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't | ||||||||||
| ZDB-ID | 1280785-0 | ||||||||||
| ISSN | 1468-1331 ; 1351-5101 ; 1471-0552 | ||||||||||
| ISSN (online) | 1468-1331 | ||||||||||
| ISSN | 1351-5101 ; 1471-0552 | ||||||||||
| DOI | 10.1111/ene.15040 | ||||||||||
| Shelf mark |
|
||||||||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 4738: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 592: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.